Fundraising Fox
/Companies
Sign in

Cardiac Insight Inc.

Bellevue, US · 4 known investors

Find your way into Cardiac Insight Inc.

Sign up to see every warm intro you have to Cardiac Insight Inc.

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Cardiac Insight Inc. team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Cardiac Insight develops handheld and wearable ECG devices for cardiac diagnostics, including the Cardea 20/20 for athlete heart screening and the Cardea SOLO for 7-day ambulatory monitoring. The company serves healthcare providers and patients seeking reliable electrocardiogram analysis and cardiac evaluation.

BiotechHardwareHealthtechMedical Devices

Founders & leadership

DL
David LinkerCo-founder
DDDr. Dave Hadley
Dr. Dave HadleyFounder
DVDr. Vic Froelicher
Dr. Vic FroelicherFounder
BW
Bill WillisPresident2014–2017Bill Willis has more than 30 years of experience in medical device and healthcare leadership, including founding iCardia Healthcare and serving as President and CEO of iRhythm Technologies, CardioNet, and LifeWatch, as well as leading Yor Labs' cardiac ultrasound technology development. He holds seven patents in cardiac diagnostics and digital health, and currently serves as Executive Officer of Cardiac Insight Inc., which develops handheld and wearable ECG devices for cardiac monitoring and diagnosis.
BH
Brad HarlowExecutive
RD
Robert deGavreExecutive
MS
Mike SchuhCFO
BO
Bob OdellExecutive

Board

TCTom Clement
Tom ClementBoard directorMedical Device Executive and former Chairman of WBBA at The W Fund
LG
Lex GambleBoard director
HR
Hemanth ReddyBoard director
RM
Richard MartinBoard director

Investors · 4

Keiretsu Forumlisted by Keiretsu ForumSan Francisco East Bay · $250K – $2M
SeaChangelisted by SeaChange$250K – $1M
The W Fundlisted by The W FundSeattle · $500K

How we know: The W Fund's portfolio page · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$35.3M disclosed across 8 rounds · 2014–2022

▶$11.6MraisedMar 2022 · 6 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Hyoung Min KimExecutive Officer, Director
  • Michael SchuhExecutive Officer
  • Robert OdellExecutive Officer
  • Ann DemareeExecutive Officer
  • David HadleyExecutive Officer
  • Daniel TylutkiExecutive Officer
  • Stacy SprouseExecutive Officer
  • Kurt NoltensmeyerExecutive Officer
Offering amount
$12.1M
Amount sold
$11.6M
Minimum investment
$20K
First sale
Mar 2022
Incorporated
Corporation, Washington
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4.7MraisedAug 2019 · 12 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Richard MartinDirector
  • Bob OdellExecutive Officer
  • Mike SchuhExecutive Officer
  • Brad HarlowExecutive Officer, Director
  • Kirby CramerDirector
  • Robert deGavreDirector
  • Clifford StocksDirector
Offering amount
$11.8M
Amount sold
$4.7M
First sale
Jul 2019
Incorporated
Corporation, Washington
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.8MraisedAug 2017 · 31 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert deGavreDirector
  • Bob OdellExecutive Officer
  • Kirby CramerDirector
  • Mike SchuhExecutive Officer
  • Tom ClementDirector
  • Brad HarlowExecutive Officer, Director
  • Robert HauserDirector
  • Richard MartinDirector
  • Lex GambleDirector
  • Bill WillisExecutive Officer
Offering amount
$10M
Amount sold
$2.8M
First sale
May 2017
Incorporated
Corporation, Washington
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1MraisedDec 2016 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • David LinkerExecutive Officer, Director
  • Brad HarlowExecutive Officer, Director
  • Lex GambleDirector
  • Kirby CramerDirector
  • Tom ClementDirector
  • Bob OdellExecutive Officer
  • Bill WillisExecutive Officer
  • Mike SchuhExecutive Officer
  • Hemanth ReddyDirector
  • Robert deGavreDirector
  • Richard MartinDirector
  • Robert HauserDirector
Offering amount
$2.4M
Amount sold
$1M
First sale
Nov 2016
Incorporated
Corporation, Washington
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.5MraisedApr 2016 · 30 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • David LinkerExecutive Officer, Director
  • Mike SchuhExecutive Officer
  • Kirby CramerDirector
  • Bob OdellExecutive Officer
  • Hemanth ReddyDirector
  • Robert deGavreDirector
  • Tom ClementDirector
  • Richard MartinDirector
  • Robert HauserDirector
  • Brad HarlowExecutive Officer, Director
  • Lex GambleDirector
  • Bill WillisExecutive Officer
Offering amount
$5M
Amount sold
$2.5M
First sale
Apr 2016
Incorporated
Corporation, Washington
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.5MraisedSep 2015 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Bill WillisExecutive Officer
  • Hemanth ReddyDirector
  • Tom ClementDirector
  • Brad HarlowExecutive Officer, Director
  • Richard MartinDirector
  • Robert deGavreExecutive Officer, Director
  • David LinkerExecutive Officer, Director
  • Lex GambleDirector
  • Mike SchuhExecutive Officer
  • Bob OdellExecutive Officer
  • Robert HauserDirector
  • Kirby CramerDirector
Offering amount
$3.5M
Amount sold
$3.5M
First sale
Sep 2015
Incorporated
Corporation, Washington
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$7.1MraisedJul 2014 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Mike SchuhExecutive Officer
  • David LinkerExecutive Officer, Director
  • Bob OdellExecutive Officer
  • Richard MartinDirector
  • Robert deGavreExecutive Officer, Director
  • Kirby CramerDirector
  • Bill WillisExecutive Officer
  • Lex GambleDirector
  • Robert HauserDirector
  • Tom ClementDirector
  • Brad HarlowExecutive Officer, Director
Offering amount
$9.1M
Amount sold
$7.1M
First sale
Jun 2014
Incorporated
Corporation, Washington
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2MraisedJan 2014 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Bill WillisExecutive Officer
  • Robert deGavreExecutive Officer, Director
  • Richard MartinDirector
  • Mike SchuhExecutive Officer
  • Brad HarlowExecutive Officer, Director
  • Robert HauserDirector
  • David LinkerExecutive Officer, Director
  • Lex GambleDirector
  • Kirby CramerDirector
  • Tom ClementDirector
  • Bob OdellExecutive Officer
Offering amount
$2M
Amount sold
$2M
First sale
Jan 2014
Incorporated
Corporation, Washington
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 2

Rf SurgicalMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
Boston ScientificBoston Scientific supports external researcher-initiated studies through its Investigator Sponsored Research program, which funds independent investigations addressing disease understanding and treatment gaps of interest to the medical community.

Companies working in the same space as Cardiac Insight Inc..

Frequently asked questions

What does Cardiac Insight Inc. do?
Cardiac Insight develops handheld and wearable ECG devices for cardiac diagnostics, including the Cardea 20/20 for athlete heart screening and the Cardea SOLO for 7-day ambulatory monitoring. The company serves healthcare providers and patients seeking reliable electrocardiogram analysis and cardiac evaluation.
Who founded Cardiac Insight Inc.?
Cardiac Insight Inc. was founded by David Linker, Dr. Dave Hadley, Dr. Vic Froelicher.
Who are Cardiac Insight Inc.'s investors?
Cardiac Insight Inc.'s investors include Cowles Ventures, Keiretsu Forum, SeaChange, The W Fund.
How much funding has Cardiac Insight Inc. raised?
Cardiac Insight Inc. has disclosed $35.3M raised across 8 rounds.
Where is Cardiac Insight Inc. headquartered?
Cardiac Insight Inc. is headquartered in Bellevue, US.